Trial Profile
Efficacy of an Ecabet Sodium and Proton Pump Inhibitor (PPI) Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection: A Prospective Randomized Controlled Trial.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ecabet (Primary) ; Lansoprazole
- Indications Gastric ulcer
- Focus Therapeutic Use
- 08 Mar 2011 New trial record